A Randomised Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2018
At a glance
- Drugs Ibuprofen (Primary)
- Indications Patent ductus arteriosus
- Focus Therapeutic Use
- Acronyms PDA RCT; PDA trial
- 05 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Jun 2020.
- 05 Sep 2018 Status changed has been changed to recruiting.
- 05 Oct 2017 New trial record